Literature DB >> 32104749

Influence of Ethnicity on Outcomes of Diabetes Inpatient Hypoglycemia: an Australian Perspective.

Usman H Malabu1,2,3, Oyelola Adegboye3, Oliver G Hayes1, Alexandra Ryan1, Venkat N Vangaveti2, Shaurya Jhamb2, Kelvin Robertson1, Kunwarjit S Sangla1,2.   

Abstract

AIMS: To evaluate outcomes of diabetic inpatient hypoglycemia among Aboriginal and Torres Strait Islander (ATSI) compared with Australian Caucasian patients.
METHODS: A retrospective audit of diabetic patients aged > 18 years admitted at a regional hospital general ward between April 1, 2015, and March 31, 2016, was analyzed. The database contains clinical information at the time of admission and initial discharge and readmission within 4 weeks thereafter.
RESULTS: A total of 1618 (of 6027) patients were admitted with diabetes representing 23.7% of the total ward admissions, of which 484 (29.9%) had inpatient hypoglycemia. Of the 91 patients with available data analyzed, ATSI origin with inpatient hypoglycemia was associated with longer length of stay (LOS) (hazard ratio [HR], 2.1, 95% confidence interval [CI], 1.2-3.5), whereas severe hypoglycemia (≤ 2.2 mmol/L) in both ATSI and non-ATSI was significantly associated with longer LOS (HR, 2.3; 95% CI, 1.2-4.2). No significant differences in LOS were found for gender, age, and Carlson comorbidity index (CCI). The adjusted model for likelihood of readmission, gender, indigenous status, and CCI were not significant risk factors for readmission to the hospital. Readmitted patients were older (50-59 years vs < 50 years, P = 0.001; 60-69 years vs < 50 years, P = 0.032; 70+ years vs < 50 years, P = 0.031).
CONCLUSION: We reported high rate of inpatient hypoglycemia in our study population. Indigenous Australian diabetic patients with inpatient hypoglycemia had significantly longer LOS compared with non-Indigenous Caucasian counterparts. Further prospective studies on a larger population are needed to confirm our findings. © Endocrine Society 2020.

Entities:  

Keywords:  Indigenous Australian; diabetes; inpatient hypoglycemia; length of hospital stay

Year:  2020        PMID: 32104749      PMCID: PMC7039405          DOI: 10.1210/jendso/bvaa009

Source DB:  PubMed          Journal:  J Endocr Soc        ISSN: 2472-1972


  21 in total

Review 1.  Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2016-11-21       Impact factor: 19.112

2.  Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes.

Authors:  Mikhail Kosiborod; Saif S Rathore; Silvio E Inzucchi; Frederick A Masoudi; Yongfei Wang; Edward P Havranek; Harlan M Krumholz
Journal:  Circulation       Date:  2005-06-06       Impact factor: 29.690

3.  Risk factors and outcome differences in hypoglycaemia-related hospital admissions: A case-control study in England.

Authors:  Francesco Zaccardi; David R Webb; Melanie J Davies; Nafeesa N Dhalwani; Gemma Housley; Dominic Shaw; James W Hatton; Kamlesh Khunti
Journal:  Diabetes Obes Metab       Date:  2017-04-21       Impact factor: 6.577

4.  Inpatient glucose control: a glycemic survey of 126 U.S. hospitals.

Authors:  Curtiss B Cook; Gail L Kongable; Daniel Jason Potter; Victor J Abad; Dora E Leija; Marcy Anderson
Journal:  J Hosp Med       Date:  2009-11       Impact factor: 2.960

5.  Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward.

Authors:  Alexander Turchin; Michael E Matheny; Maria Shubina; James V Scanlon; Bonnie Greenwood; Merri L Pendergrass
Journal:  Diabetes Care       Date:  2009-07       Impact factor: 19.112

6.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

7.  Economic and clinical impact of inpatient diabetic hypoglycemia.

Authors:  Suellen M Curkendall; Jaime L Natoli; Charles M Alexander; Brian H Nathanson; Tracy Haidar; Robert W Dubois
Journal:  Endocr Pract       Date:  2009 May-Jun       Impact factor: 3.443

8.  Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial).

Authors:  Guillermo E Umpierrez; Dawn Smiley; Ariel Zisman; Luz M Prieto; Andres Palacio; Miguel Ceron; Alvaro Puig; Roberto Mejia
Journal:  Diabetes Care       Date:  2007-05-18       Impact factor: 19.112

9.  Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction.

Authors:  Mikhail Kosiborod; Silvio E Inzucchi; Abhinav Goyal; Harlan M Krumholz; Frederick A Masoudi; Lan Xiao; John A Spertus
Journal:  JAMA       Date:  2009-04-15       Impact factor: 56.272

10.  Understanding hypoglycemia in hospitalized patients.

Authors:  Raphael D Hulkower; Rena M Pollack; Joel Zonszein
Journal:  Diabetes Manag (Lond)       Date:  2014-03
View more
  1 in total

1.  A prospective six-month audit of inpatient hypoglycemia in step-down general medical and geriatric wards.

Authors:  Penny Dwyer; Jocelyn J Drinkwater; P Gerry Fegan; Wendy A Davis; Timothy M E Davis
Journal:  Int J Med Sci       Date:  2021-10-03       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.